02Jan 2018

ONCOSTATIN-M EXPRESSION IN ORAL SQUAMOUS CELL CARCINOMA.

  • Lecturer, Oral and Maxillofacial Pathology Department Faculty of Oral and Dental Medicine Ahram Canadian University.
  • Professor of Oral and Maxillofacial Pathology, Faculty of Oral and Dental Medicine, Cairo University.
  • Professor of Oral and Maxillofacial Pathology, Faculty of Oral and Dental Medicine, Cairo University.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Growth of malignant lesions is invariably associated with the presence of inflammatory cells at the primary site. It is hypothesized that tumor cells evade the growth inhibitory effects of cytokines present in the tumor microenvironment. Oncostatin -M (OSM) is an inflammatory cytokine produced by macrophages and T lymphocytes as well as tumor cells, it inhibits the proliferation and induces differentiation of a number of types of tumors. This study aimed to assess OSM expression in oral squamous cell carcinoma. Methods: Ex vivo study done on thirty (OSCC) cases obtained from paraffin blocks and ten normal epithelial tissues used as control. For each case immunohistochemical examination of OSM expression in different grades of OSCC was done. Results: OSM immunohistochemical expression showed statistical significant difference between different grades of OSCC and also between them and control (p<0.0001). Conclusion: This study found that OSM expression is inversely proportional with tumor differentiation suggesting that it may be used as biomarker in OSCC.

  1. Cai, J., P. S. Gill, R. Masood, P. Chandrasoma, B. Jung, R. E. Law, and S. F. Radka. "Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma."The American journal of pathology?145, no. 1 (1994): 74.
  2. Chuerduangphui, Jureeporn, Chamsai Pientong, Ponlatham Chaiyarit, Natcha Patarapadungkit, Apinya Chotiyano, Bunkerd Kongyingyoes, Supannee Promthet, Piyawut Swangphon, Weerayut Wongjampa, and Tipaya Ekalaksananan. "Effect of human papillomavirus 16 oncoproteins on oncostatin M upregulation in oral squamous cell carcinoma."Medical Oncology?33, no. 8 (2016): 1-11.
  3. Dissanayaka, Waruna Lakmal, Gayani Pitiyage, Pallegoda Vithanage Ranjith Kumarasiri, Rubasinha Liyanage Pemith Ranura Liyanage, Kumara Dayanath Dias, and Wanninayake Mudiyanselage Tilakaratne. "Clinical and histopathologic parameters in survival of oral squamous cell carcinoma."Oral surgery, oral medicine, oral pathology and oral radiology?113, no. 4 (2012): 518-525.
  4. Diveu, Caroline, Emilie Venereau, Josy Froger, Elisa Ravon, Linda Grimaud, Fran?ois Rousseau, Sylvie Chevalier, and Hugues Gascan. "Molecular and functional characterization of a soluble form of oncostatin M/interleukin-31 shared receptor."Journal of Biological Chemistry?281, no. 48 (2006): 36673-36682.
  5. Elbjeirami, Wafa M., Elizabeth M. Donnachie, Alan R. Burns, and C. Wayne Smith. "Endothelium-derived GM-CSF influences expression of oncostatin M."American Journal of Physiology-Cell Physiology?301, no. 4 (2011): C947-C953.
  6. Fossey, Stacey L., Misty D. Bear, William C. Kisseberth, Michael Pennell, and Cheryl A. London. "Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines."BMC cancer?11, no. 1 (2011): 125.
  7. Garc?a-Tu??n, Ignacio, Monica Ricote, Antonio Ruiz, Benito Fraile, Ricardo Paniagua, and Mar Royuela. "OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative)."Cancer investigation?26, no. 3 (2008): 222-229.
  8. Guo, L., C. Chen, M. Shi, F. Wang, X. Chen, D. Diao, M. Hu, M. Yu, L. Qian, and N. Guo. "Stat3-coordinated Lin-28?let-7?HMGA2 and miR-200?ZEB1 circuits initiate and maintain oncostatin M-driven epithelial?mesenchymal transition."Oncogene?32, no. 45 (2013): 5272-5282.
  9. Hanahan, Douglas, and Robert A. Weinberg. "Hallmarks of cancer: the next generation."cell?144, no. 5 (2011): 646-674.
  10. Hirano, Toshio, Katsuhiko Ishihara, and Masahiko Hibi. "Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors."Oncogene?19, no. 21 (2000): 2548.
  11. Ibrahim, Amal S., Hussein M. Khaled, Nabiel NH Mikhail, Hoda Baraka, and Hossam Kamel. "Cancer incidence in Egypt: results of the national population-based cancer registry program."Journal of cancer epidemiology?2014 (2014).
  12. Kausar, Tasneem, Rinu Sharma, Md Raghibul Hasan, Anoop Saraya, Tushar K. Chattopadhyay, Siddartha Datta Gupta, and Ranju Ralhan. "Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma."Cellular Oncology?34, no. 3 (2011): 177-187.
  13. Kozlowska, K., Małgorzata Zarzeczna, and Mirosława Cichorek. "A comparative study on oncostatin M secretion by transplantable melanoma cells with regard to their biological properties and progression."FOLIA MORPHOLOGICA-WARSZAWA-ENGLISH EDITION-?60, no. 2 (2001): 85-90.
  14. Lacreusette, A., J. M. Nguyen, M. C. Pandolfino, A. Khammari, B. Dreno, Y. Jacques, A. Godard, and F. Blanchard. "Loss of oncostatin M receptor β in metastatic melanoma cells."Oncogene?26, no. 6 (2007): 881-892.
  15. O'hara, K. A., M‐ Kedda, P. J. Thompson, and D. A. Knight. "Oncostatin M: an interleukin‐6‐like cytokine relevant to airway remodelling and the pathogenesis of asthma."Clinical & Experimental Allergy?33, no. 8 (2003): 1026-1032.
  16. Plun-Favreau, H?l?ne, David Perret, Caroline Diveu, Josy Froger, Sylvie Chevalier, Eric Leli?vre, Hugues Gascan, and Marie Chabbert. "Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor."Journal of Biological Chemistry?278, no. 29 (2003): 27169-27179.
  17. Radtke, Simone, Heike M. Hermanns, Claude Haan, Hildegard Schmitz-Van de Leur, Hugues Gascan, Peter C. Heinrich, and Iris Behrmann. "Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression."Journal of Biological Chemistry?277, no. 13 (2002): 11297-11305.
  18. Richards, Carl D. "The enigmatic cytokine oncostatin M and roles in disease."ISRN inflammation
  19. Royuela, Mar, Monica Ricote, Melanie S. Parsons, Ignacio Garc?a‐Tu??n, Ricardo Paniagua, and Maria P. De Miguel. "Immunohistochemical analysis of the IL‐6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate."The Journal of pathology?202, no. 1 (2004): 41-49.
  20. Snyder, Marylynn, Xin-Yun Huang, and J. Jillian Zhang. "Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration."Journal of Biological Chemistry?286, no. 45 (2011): 38886-38893
  21. Somasundaram, Rajan, Martin Ruehl, Benjamin Schaefer, Monika Schmid, Renate Ackermann, Ernst O. Riecken, Martin Zeitz, and Detlef Schuppan. "Interstitial collagens I, III, and VI sequester and modulate the multifunctional cytokine oncostatin M."Journal of Biological Chemistry?277, no. 5 (2002): 3242-3246.
  22. Tran, Tien-Anh, Jeffrey S. Ross, Christine E. Sheehan, and J. Andrew Carlson. "Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma."Modern Pathology?13, no. 4 (2000): 427-432.
  23. Wallace, Philip M., John F. MacMaster, Katherine A. Rouleau, T. Joseph Brown, James K. Loy, Karen L. Donaldson, and Alan F. Wahl. "Regulation of inflammatory responses by oncostatin M."The Journal of Immunology?162, no. 9 (1999): 5547-5555.
  24. West, Nathan R., Leigh C. Murphy, and Peter H. Watson. "Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer."Endocrine-related cancer?19, no. 2 (2012): 181-195.
  25. Zarling, Joyce M., Mohammed Shoyab, Hans Marquardt, Marcia B. Hanson, Mario N. Lioubin, and George J. Todaro. "Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells."Proceedings of the National Academy of Sciences?83, no. 24 (1986): 9739-9743.
  26. Zamarron B.F., Chen W. ?Dual roles of immune cells and their factors in cancer development and progression?International Journal of Biological Sciences, 2011; vol. 7, no. 5, pp. 651?658.
  27. Zhang, Jing, and Jinsong Liu. "Tumor stroma as targets for cancer therapy."Pharmacology & therapeutics?137, no. 2 (2013): 200-215.

[Noha Shaban Shams, louloua Mohamed Fathy and Amal Hassan Abd-El Rahman. (2018); ONCOSTATIN-M EXPRESSION IN ORAL SQUAMOUS CELL CARCINOMA. Int. J. of Adv. Res. 6 (Jan). 22-28] (ISSN 2320-5407). www.journalijar.com

Noha Shaban Shams
1- Lecturer, Oral and Maxillofacial Pathology Department Faculty of Oral and Dental Medicine Ahram Canadian University

DOI:

Article DOI: 10.21474/IJAR01/6178      
DOI URL: http://dx.doi.org/10.21474/IJAR01/6178

Download Full Paper

Download PDF No. of Downloads: 19 | No. of Views: 140